Crosstalk between white adipose tissue and skin: Unraveling its role in psoriasis pathogenesis (Review)
- Authors:
- Qiuhe Song
- Pengfei Xu
- Qipeng Xiao
- Chaowen Zhang
- Yousheng Mao
-
Affiliations: Department of Dermatology, Affiliated Hospital of Jiujiang University, Jiujiang, Jiangxi 332000, P.R. China - Published online on: April 11, 2025 https://doi.org/10.3892/mmr.2025.13534
- Article Number: 169
-
Copyright: © Song et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
|
Greb JE, Goldminz AM, Elder JT, Lebwohl MG, Gladman DD, Wu JJ, Mehta NN, Finlay AY and Gottlieb AB: Psoriasis. Nat Rev Dis Primers. 2:160822016. View Article : Google Scholar : PubMed/NCBI | |
|
Boehncke WH and Schön MP: Psoriasis. Lancet. 386:983–994. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Fülle M, Metze D, Böer-Auer A, Osada N and Braun SA: Psoriasis on the leg: Site-specific histopathological and immuno-histochemical features and diagnostic difficulties. Acta Derm Venereol. 101:adv004532021.PubMed/NCBI | |
|
Ma F, Plazyo O, Billi AC, Tsoi LC, Xing X, Wasikowski R, Gharaee-Kermani M, Hile G, Jiang Y, Harms PW, et al: Single cell and spatial sequencing define processes by which keratinocytes and fibroblasts amplify inflammatory responses in psoriasis. Nat Commun. 14:34552023. View Article : Google Scholar : PubMed/NCBI | |
|
Han Q, Niu X, Hou R, Li J, Liu Y, Li X, Li J, Li Y, Zhang K and Wu Y: Dermal mesenchymal stem cells promoted adhesion and migration of endothelial cells by integrin in psoriasis. Cell Biol Int. 45:358–367. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Griffiths CEM, Armstrong AW, Gudjonsson JE and Barker JNWN: Psoriasis. Lancet. 397:1301–1315. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Singh R, Koppu S, Perche PO and Feldman SR: The cytokine mediated molecular pathophysiology of psoriasis and its clinical implications. Int J Mol Sci. 22:127932021. View Article : Google Scholar : PubMed/NCBI | |
|
Alajroush WA, Alrshid AI, Alajlan AH, Alsalamah YB, Alhumaidan MI, Alhoumedan AI, Alrasheed MI, Alowairdhi YA, Alowirdi F, Aljoufi AZ, et al: Psoriasis and metabolic disorders: A comprehensive meta-analysis of million adults worldwide. Cureus. 16:e520992024.PubMed/NCBI | |
|
Budu-Aggrey A, Brumpton B, Tyrrell J, Watkins S, Modalsli EH, Celis-Morales C, Ferguson LD, Vie GÅ, Palmer T, Fritsche LG, et al: Evidence of a causal relationship between body mass index and psoriasis: A mendelian randomization study. PLoS Med. 16:e10027392019. View Article : Google Scholar : PubMed/NCBI | |
|
Leite BF, Morimoto MA, Gomes C, de Carvalho Klemz BN, de Souza Genaro P, Damasceno NRT, Szejnfeld VL and de Medeiros Pinheiro M: Higher bodily adiposity, fat intake, and cholesterol serum levels are associated with higher disease activity in psoriatic arthritis patients: Is there a link among fat and skin and joint involvement? Lipids Health Dis. 19:212020. View Article : Google Scholar : PubMed/NCBI | |
|
Park SH, Lee KA, Choi JH, Park S, Kim DW and Jung SY: Impact of obesity on the IL-6 immune marker and Th17 immune cells in C57BL/6 mice models with imiquimod-induced psoriasis. Int J Mol Sci. 24:55922023. View Article : Google Scholar : PubMed/NCBI | |
|
Paroutoglou K, Papadavid E, Christodoulatos GS and Dalamaga M: Deciphering the association between psoriasis and obesity: Current evidence and treatment considerations. Curr Obes Rep. 9:165–178. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Malavazos AE, Meregalli C, Sorrentino F, Vignati A, Dubini C, Scravaglieri V, Basilico S, Boniardi F, Spagnolo P, Malagoli P, et al: Semaglutide therapy decreases epicardial fat inflammation and improves psoriasis severity in patients affected by abdominal obesity and type-2 diabetes. Endocrinol Diabetes Metab Case Rep. 2023:23–0017. 2023.PubMed/NCBI | |
|
Corbetta S, Angioni R, Cattaneo A, Beck-Peccoz P and Spada A: Effects of retinoid therapy on insulin sensitivity, lipid profile and circulating adipocytokines. Eur J Endocrinol. 154:83–86. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Horwitz A and Birk R: Adipose tissue hyperplasia and hypertrophy in common and syndromic obesity-the case of BBS obesity. Nutrients. 15:34452023. View Article : Google Scholar : PubMed/NCBI | |
|
Corvera S, Solivan-Rivera J and Loureiro ZY: Angiogenesis in adipose tissue and obesity. Angiogenesis. 25:439–453. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Kawai T, Autieri MV and Scalia R: Adipose tissue inflammation and metabolic dysfunction in obesity. Am J Physiol Cell Physiol. 320:C375–C391. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Ruiz-Ojeda FJ, Méndez-Gutiérrez A, Aguilera CM and Plaza-Díaz J: Extracellular matrix remodeling of adipose tissue in obesity and metabolic diseases. Int J Mol Sci. 20:48882019. View Article : Google Scholar : PubMed/NCBI | |
|
Kiełbowski K, Bakinowska E, Ostrowski P, Pala B, Gromowska E, Gurazda K, Dec P, Modrzejewski A and Pawlik A: The role of adipokines in the pathogenesis of psoriasis. Int J Mol Sci. 24:63902023. View Article : Google Scholar : PubMed/NCBI | |
|
Guan J, Feng J, Xu M, Liu M, He Y and Lu F: Adipokines-enriched adipose extract restores skin barrier and ameliorates inflammatory dysregulation in an atopic dermatitis mouse model. Plast Reconstr Surg. 154:701e–712e. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Caton PW, Evans EA, Philpott MP and Hannen RF: Can the skin make you fat? A role for the skin in regulating adipose tissue function and whole-body glucose and lipid homeostasis. Curr Opin Pharmacol. 37:59–64. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Mizutani K, Shirakami E, Ichishi M, Matsushima Y, Umaoka A, Okada K, Yamaguchi Y, Watanabe M, Morita E and Yamanaka K: systemic dermatitis model mice exhibit atrophy of visceral adipose tissue and increase stromal cells via skin-derived inflammatory cytokines. Int J Mol Sci. 21:33672020. View Article : Google Scholar : PubMed/NCBI | |
|
Pestel J, Chehimi M, Bonhomme M, Robert M, Vidal H and Eljaafari A: IL-17A contributes to propagation of inflammation but does not impair adipogenesis and/or insulin response, in adipose tissue of obese individuals. Cytokine. 126:1548652020. View Article : Google Scholar : PubMed/NCBI | |
|
Ueyama T, Sakuma M, Nakatsuji M, Uebi T, Hamada T, Aiba A and Saito N: Rac-Dependent signaling from keratinocytes promotes differentiation of intradermal white adipocytes. J Invest Dermatol. 140:75–84.e6. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Kovács D, Fazekas F, Oláh A and Törőcsik D: Adipokines in the skin and in dermatological diseases. Int J Mol Sci. 21:90482020. View Article : Google Scholar : PubMed/NCBI | |
|
Hwang J, Yoo JA, Yoon H, Han T, Yoon J, An S, Cho JY and Lee J: The role of leptin in the association between obesity and psoriasis. Biomol Ther (Seoul). 29:11–21. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Soujanya KV and Jayadeep AP: Obesity-associated biochemical markers of inflammation and the role of grain phytochemicals. J Food Biochem. 46:e142572022. View Article : Google Scholar : PubMed/NCBI | |
|
Wolf RM, Steele KE, Peterson LA, Magnuson TH, Schweitzer MA and Wong GW: Lower circulating C1q/TNF-related protein-3 (CTRP3) levels are associated with obesity: A cross-sectional study. PLoS One. 10:e01339552015. View Article : Google Scholar : PubMed/NCBI | |
|
Słuczanowska-Głabowska S, Staniszewska M, Marchlewicz M, Duchnik E, Łuczkowska K, Safranow K, Machaliński B and Pawlik A: Adiponectin, leptin and resistin in patients with psoriasis. J Clin Med. 12:6632023. View Article : Google Scholar : PubMed/NCBI | |
|
Gerdes S, Pinter A, Biermann M, Papavassilis C and Reinhardt M: Adiponectin levels in a large pooled plaque psoriasis study population. J Dermatolog Treat. 31:531–534. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Shibata S, Tada Y, Hau CS, Mitsui A, Kamata M, Asano Y, Sugaya M, Kadono T, Masamoto Y, Kurokawa M, et al: Adiponectin regulates psoriasiform skin inflammation by suppressing IL-17 production from γδ-T cells. Nat Commun. 6:76872015. View Article : Google Scholar : PubMed/NCBI | |
|
Gerdes S, Osadtschy S, Rostami-Yazdi M, Buhles N, Weichenthal M and Mrowietz U: Leptin, adiponectin, visfatin and retinol-binding protein-4-mediators of comorbidities in patients with psoriasis? Exp Dermatol. 21:43–47. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Oh J, Lee Y, Oh SW, Li T, Shin J, Park SH and Lee J: The role of adiponectin in the skin. Biomol Ther (Seoul). 30:221–231. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Kochumon S, Hasan A, Al-Rashed F, Sindhu S, Thomas R, Jacob T, Al-Sayyar A, Arefanian H, Al Madhoun A, Al-Ozairi E, et al: Increased adipose tissue expression of IL-23 associates with inflammatory markers in people with high LDL cholesterol. Cells. 11:30722022. View Article : Google Scholar : PubMed/NCBI | |
|
Ohn J, Been KW, Kim JY, Kim EJ, Park T, Yoon HJ, Ji JS, Okada-Iwabu M, Iwabu M, Yamauchi T, et al: Discovery of a transdermally deliverable pentapeptide for activating AdipoR1 to promote hair growth. EMBO Mol Med. 13:e137902021. View Article : Google Scholar : PubMed/NCBI | |
|
Suh JH, Lee Y, Ohn J, Kim EJ, Kim TG, Jo SJ, Kim SJ and Chung JH: Adiponectin-derived pentapeptide ameliorates psoriasiform skin inflammation by suppressing IL-17 production in γδT cells. J Dermatol Sci. 106:45–52. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Jin T, Sun Z, Chen X, Wang Y, Li R, Ji S and Zhao Y: Serum human beta-defensin-2 is a possible biomarker for monitoring response to JAK inhibitor in psoriasis patients. Dermatology. 233:164–169. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Tsang JYS, Li D, Ho D, Peng J, Xu A, Lamb J, Chen Y and Tam PKH: Novel immunomodulatory effects of adiponectin on dendritic cell functions. Int Immunopharmacol. 11:604–609. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
D'Amico F, Costantino G, Salvatorelli L, Ramondetta A, De Pasquale R, Sortino MA and Merlo S: Inverse correlation between the expression of AMPK/SIRT1 and NAMPT in psoriatic skin: A pilot study. Adv Med Sci. 67:262–268. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Shen H, Sha Y, Huang J, Mao AQ, Zhang T, Wu MY, Sun F, Yu YY, Cheng ZQ and Gong YT: The roles of AMPK-mediated autophagy and mitochondrial autophagy in a mouse model of imiquimod-induced psoriasis. Am J Transl Res. 13:12626–12637. 2021.PubMed/NCBI | |
|
Wang R, Yu C, Tang Z, Sun J, Wang Y, Zhao Z, Lin B and Li C: Leptin induces altered differentiation of keratinocytes by inducing insulin resistance: Implications for metabolic syndrome-induced resistance of psoriatic therapy. J Dermatolog Treat. 35:23093052024. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu KJ, Zhang C, Li M, Zhu CY, Shi G and Fan YM: Leptin levels in patients with psoriasis: A meta-analysis. Clin Exp Dermatol. 38:478–483. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Johnston A, Arnadottir S, Gudjonsson JE, Aphale A, Sigmarsdottir AA, Gunnarsson SI, Steinsson JT, Elder JT and Valdimarsson H: Obesity in psoriasis: Leptin and resistin as mediators of cutaneous inflammation. Br J Dermatol. 159:342–350. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Su X, Cheng Y and Chang D: The important role of leptin in modulating the risk of dermatological diseases. Front Immunol. 11:5935642020. View Article : Google Scholar : PubMed/NCBI | |
|
Su X, Zhang G, Cheng Y and Wang B: Leptin in skin disease modulation. Clin Chim Acta. 516:8–14. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Yu Y, Liu Y, Shi FD, Zou H, Matarese G and La Cava A: Cutting edge: Leptin-induced RORγt expression in CD4+ T cells promotes Th17 responses in systemic lupus erythematosus. J Immunol. 190:3054–3058. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Walendzik K, Kopcewicz M, Bukowska J, Panasiewicz G, Szafranska B and Gawronska-Kozak B: The transcription factor FOXN1 regulates skin adipogenesis and affects susceptibility to diet-induced obesity. J Invest Dermatol. 140:1166–1175.e9. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
De Rosa V, Procaccini C, Calì G, Pirozzi G, Fontana S, Zappacosta S, La Cava A and Matarese G: A key role of leptin in the control of regulatory T cell proliferation. Immunity. 26:241–255. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Wang W, Zhang BT, Jiang QL, Zhao HQ, Xu Q, Zeng Y, Xu JY and Jiang J: Leptin receptor antagonist attenuates experimental autoimmune thyroiditis in mice by regulating Treg/Th17 cell differentiation. Front Endocrinol (Lausanne). 13:10425112022. View Article : Google Scholar : PubMed/NCBI | |
|
Calautti E, Avalle L and Poli V: Psoriasis: A STAT3-centric view. Int J Mol Sci. 19:1712018. View Article : Google Scholar : PubMed/NCBI | |
|
Markaki A, Gkouskou K, Stylianou K, Dermitzaki E, Perakis K, Margioris A and Daphnis E: Relationship between adiposity, adipokines, inflammatory markers and lipid profile in hemodialysis patients. Eur Rev Med Pharmacol Sci. 18:1496–1498. 2014.PubMed/NCBI | |
|
Ikeda K, Morizane S, Akagi T, Hiramatsu-Asano S, Tachibana K, Yahagi A, Iseki M, Kaneto H, Wada J, Ishihara K, et al: Obesity and dyslipidemia synergistically exacerbate psoriatic skin inflammation. Int J Mol Sci. 23:43122022. View Article : Google Scholar : PubMed/NCBI | |
|
Kanda N and Watanabe S: Leptin enhances human beta-defensin-2 production in human keratinocytes. Endocrinology. 149:5189–5198. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Khanna D, Khanna S, Khanna P, Kahar P and Patel BM: Obesity: A chronic low-grade inflammation and its markers. Cureus. 14:e227112022.PubMed/NCBI | |
|
Žužul K, Kunjko K, Milošević M, Tončić RJ, Kelava T and Hadžavdić SL: The association between the severity of psoriasis and obesity based on the analysis of visceral fat index and serum levels of tumor necrosis factor-α, interleukin-6, and resistin. Acta Dermatovenerol Croat. 30:8–17. 2022.PubMed/NCBI | |
|
Srikanth M and Rasool M: Resistin-A plausible therapeutic target in the pathogenesis of psoriasis. Immunol Invest. 53:115–159. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Shao S, Fang H, Dang E, Xue K, Zhang J, Li B, Qiao H, Cao T, Zhuang Y, Shen S, et al: Neutrophil extracellular traps promote inflammatory responses in psoriasis via activating epidermal TLR4/IL-36R crosstalk. Front Immunol. 10:7462019. View Article : Google Scholar : PubMed/NCBI | |
|
Taouis M and Benomar Y: Is resistin the master link between inflammation and inflammation-related chronic diseases? Mol Cell Endocrinol. 533:1113412021. View Article : Google Scholar : PubMed/NCBI | |
|
Mahmoud MA, Mohamed RW, Attia FM, Atwa MA and Abdel-Moneim SM: Expression of telomerase reverse transcriptase in psoriatic lesional skin. Dis Markers. 22:265–269. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang F, Li H, Zhou Y, Gu Y and Wang L: Caveolin-1 expression in different types of psoriatic lesions: Analysis of 66 cases. Indian J Dermatol. 59:225–229. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Huang TH, Lin CF, Alalaiwe A, Yang SC and Fang JY: Apoptotic or antiproliferative activity of natural products against keratinocytes for the treatment of psoriasis. Int J Mol Sci. 20:25582019. View Article : Google Scholar : PubMed/NCBI | |
|
Chen SS, Tang CH, Chie MJ, Tsai CH, Fong YC, Lu YC, Chen WC, Lai CT, Wei CY, Tai HC, et al: Resistin facilitates VEGF-A-dependent angiogenesis by inhibiting miR-16-5p in human chondrosarcoma cells. Cell Death Dis. 10:312019. View Article : Google Scholar : PubMed/NCBI | |
|
Sieminska I, Pieniawska M and Grzywa TM: The immunology of psoriasis-current concepts in pathogenesis. Clin Rev Allergy Immunol. 66:164–191. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Jang DI, Lee AH, Shin HY, Song HR, Park JH, Kang TB, Lee SR and Yang SH: The role of tumor necrosis factor alpha (TNF-α) in autoimmune disease and current TNF-α inhibitors in therapeutics. Int J Mol Sci. 22:27192021. View Article : Google Scholar : PubMed/NCBI | |
|
Man AM, Orăsan MS, Hoteiuc OA, Olănescu-Vaida-Voevod MC and Mocan T: Inflammation and psoriasis: A comprehensive review. Int J Mol Sci. 24:160952023. View Article : Google Scholar : PubMed/NCBI | |
|
Patel AB, Tsilioni I, Weng Z and Theoharides TC: TNF stimulates IL-6, CXCL8 and VEGF secretion from human keratinocytes via activation of mTOR, inhibited by tetramethoxyluteolin. Exp Dermatol. 27:135–143. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Tan JK, Aphale A, Malaviya R, Sun Y and Gottlieb AB: Mechanisms of action of etanercept in psoriasis. J Investig Dermatol Symp Proc. 12:38–45. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Johansen C, Funding AT, Otkjaer K, Kragballe K, Jensen UB, Madsen M, Binderup L, Skak-Nielsen T, Fjording MS and Iversen L: Protein expression of TNF-alpha in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2. J Immunol. 176:1431–1438. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
de Alcantara CC, Reiche EMV and Simão ANC: Cytokines in psoriasis. Adv Clin Chem. 100:171–204. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Behfar S, Hassanshahi G, Nazari A and Khorramdelazad H: A brief look at the role of monocyte chemoattractant protein-1 (CCL2) in the pathophysiology of psoriasis. Cytokine. 110:226–231. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Purzycka-Bohdan D, Nedoszytko B, Zabłotna M, Gleń J, Szczerkowska-Dobosz A and Nowicki RJ: Chemokine profile in psoriasis patients in correlation with disease severity and pruritus. Int J Mol Sci. 23:133302022. View Article : Google Scholar : PubMed/NCBI | |
|
Chyl-Surdacka KM, Bartosińska J, Kowal M, Przepiórka-Kosińska J, Krasowska D and Chodorowska G: Assessment of visfatin concentrations in the serum of male psoriatic patients in relation to metabolic abnormalities. Adv Clin Exp Med. 29:79–84. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Hau CS, Kanda N, Noda S, Tatsuta A, Kamata M, Shibata S, Asano Y, Sato S, Watanabe S and Tada Y: Visfatin enhances the production of cathelicidin antimicrobial peptide, human β-defensin-2, human β-defensin-3, and S100A7 in human keratinocytes and their orthologs in murine imiquimod-induced psoriatic skin. Am J Pathol. 182:1705–1717. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Kanda N, Hau CS, Tada Y, Tatsuta A, Sato S and Watanabe S: Visfatin enhances CXCL8, CXCL10, and CCL20 production in human keratinocytes. Endocrinology. 152:3155–3164. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Chyl-Surdacka KM, Gerkowicz A, Bartosińska J, Kowal M, Przepiórka-Kosińska J, Surdacki G, Krasowska D and Chodorowska G: Analysis of serum chemerin concentrations in psoriatic patients in relation to metabolic abnormalities. Postepy Dermatol Alergol. 36:531–537. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Huo J, Zhang D, Hu G and Zhang Y: Chemerin/ChemR23 axis triggers an inflammatory response in keratinocytes through ROS-sirt1-NF-κB signaling. J Cell Biochem. 120:6459–6470. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang X, Yin M and Zhang LJ: Keratin 6, 16 and 17-critical barrier alarmin molecules in skin wounds and psoriasis. Cells. 8:8072019. View Article : Google Scholar : PubMed/NCBI | |
|
Lynch M, Ahern T, Sweeney CM, Malara A, Tobin AM, O'Shea D and Kirby B: Adipokines, psoriasis, systemic inflammation, and endothelial dysfunction. Int J Dermatol. 56:1103–1118. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Xue K, Shao S, Fang H, Ma L, Li C, Lu Z and Wang G: Adipocyte-derived CTRP3 exhibits anti-inflammatory effects via LAMP1-STAT3 axis in psoriasis. J Invest Dermatol. 142:1349–1359.e8. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Wang K and Zeng C: Extracellular vesicles and obesity. Adv Exp Med Biol. 1418:143–153. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Jeppesen DK, Zhang Q, Franklin JL and Coffey RJ: Extracellular vesicles and nanoparticles: Emerging complexities. Trends Cell Biol. 33:667–681. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Kumar V, Kiran S, Kumar S and Singh UP: Extracellular vesicles in obesity and its associated inflammation. Int Rev Immunol. 41:30–44. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Kranendonk MEG, Visseren FLJ, van Herwaarden JA, Nolte-'t Hoen ENM, de Jager W, Wauben MHM and Kalkhoven E: Effect of extracellular vesicles of human adipose tissue on insulin signaling in liver and muscle cells. Obesity (Silver Spring). 22:2216–2223. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang X, Chen L, Xiao B, Liu H and Su Y: Circ_0075932 in adipocyte-derived exosomes induces inflammation and apoptosis in human dermal keratinocytes by directly binding with PUM2 and promoting PUM2-mediated activation of AuroraA/NF-κB pathway. Biochem Biophys Res Commun. 511:551–558. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Meybodi MA, Nilforoushzadeh MA, KhandanDezfully N and Mansouri P: The safety and efficacy of adipose tissue-derived exosomes in treating mild to moderate plaque psoriasis: A clinical study. Life Sci. 353:1229152024. View Article : Google Scholar : PubMed/NCBI | |
|
Nussbaumerova B and Rosolova H: Obesity and dyslipidemia. Curr Atheroscler Rep. 25:947–955. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Saalbach A, Seitz AT, Kohlmann J, Kalweit L, Vogt L, Selig L, Engel KM and Simon JC: Modulation of dietary fatty acids in an open-label study improves psoriasis and dampens the inflammatory activation status. Nutrients. 15:16982023. View Article : Google Scholar : PubMed/NCBI | |
|
Herbert D, Franz S, Popkova Y, Anderegg U, Schiller J, Schwede K, Lorz A, Simon JC and Saalbach A: High-Fat diet exacerbates early psoriatic skin inflammation independent of obesity: Saturated fatty acids as key players. J Invest Dermatol. 138:1999–2009. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Stelzner K, Herbert D, Popkova Y, Lorz A, Schiller J, Gericke M, Klöting N, Blüher M, Franz S, Simon JC and Saalbach A: Free fatty acids sensitize dendritic cells to amplify TH1/TH17-immune responses. Eur J Immunol. 46:2043–2053. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Mogilenko DA, Haas JT, L'homme L, Fleury S, Quemener S, Levavasseur M, Becquart C, Wartelle J, Bogomolova A, Pineau L, et al: Metabolic and innate immune cues merge into a specific inflammatory response via the UPR. Cell. 177:1201–1216.e19. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Lopes N, McIntyre C, Martin S, Raverdeau M, Sumaria N, Kohlgruber AC, Fiala GJ, Agudelo LZ, Dyck L, Kane H, et al: Distinct metabolic programs established in the thymus control effector functions of γδ T cell subsets in tumor microenvironments. Nat Immunol. 22:179–192. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Sivasami P, Elkins C, Diaz-Saldana PP, Goss K, Peng A, Hamersky M IV, Bae J, Xu M, Pollack BP, Horwitz EM, et al: Obesity-induced dysregulation of skin-resident PPARγ+ Treg cells promotes IL-17A-mediated psoriatic inflammation. Immunity. 56:1844–1861.e6. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Cheung L, Fisher RM, Kuzmina N, Li D, Li X, Werngren O, Blomqvist L, Ståhle M and Landén NX: Psoriasis skin inflammation-induced microRNA-26b targets NCEH1 in underlying subcutaneous adipose tissue. J Invest Dermatol. 136:640–648. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu T, Yang S, Mauro TM and Man MQ: Association of epidermal biophysical properties with obesity and its implications. Skin Pharmacol Physiol. 36:165–173. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Arican O, Aral M, Sasmaz S and Ciragil P: Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm. 2005:273–279. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Sehat M, Talaei R, Dadgostar E, Nikoueinejad H and Akbari H: Evaluating serum levels of IL-33, IL-36, IL-37 and gene expression of IL-37 in patients with psoriasis vulgaris. Iran J Allergy Asthma Immunol. 17:179–187. 2018.PubMed/NCBI | |
|
Sharma N, Akkoyunlu M and Rabin RL: Macrophages-common culprit in obesity and asthma. Allergy. 73:1196–1205. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Frühbeck G, Gómez-Ambrosi J, Ramírez B, Mentxaka A, Rodríguez A, Becerril S, Reina G, Valentí V, Moncada R, Silva C and Catalán V: Corrigendum: Increased levels of interleukin-36 in obesity and type 2 diabetes fuels adipose tissue inflammation by inducing its own expression and release by adipocytes and macrophages. Front Immunol. 14:11383162023. View Article : Google Scholar : PubMed/NCBI | |
|
Mao Y, Hong KH, Liao W, Li L, Kim SJ, Xiong Y, Nam IK, Choe SK and Kwak SA: Generation of a novel transgenic zebrafish for studying adipocyte development and metabolic control. Int J Mol Sci. 22:39942021. View Article : Google Scholar : PubMed/NCBI |
